Journal of Depression and Anxiety
Open Access

Community Health Network, 6950 Hillsdale Court, Indianapolis, USA

Publications

• Case Report   
  Brexpiprazole-Induced Gynecomastia in a Thirteen-Year Old Male
  Author(s): Shilpa Puri*, Magdoline Daas, Jennifer K. Day and Calvin T. Nguyen
  
  This case reports involves a thirteen-year-old male with a history of anxiety, depression, autism spectrum disorder, and attention deficit hyperactivity disorder (ADHD) who developed significant weight gain and gynecomastia ten months after starting brexpiprazole. He had prior trials of quetiapine and aripiprazole which caused significant weight gain but did not cause gynecomastia. He had been taking sertraline and guanfacine for almost two years prior to starting brexpiprazole. Eight months later he was started on dexmethylphenidate for ADHD symptoms. There were no other recent exposures. After these symptoms developed, brexpiprazole and dexmethylphenidate were discontinued and several weeks later his gynecomastia resolved. Dexmethylphenidate is not known to cause gynecomastia. Although atypical antipsychotics have been known to cause gynecomastia, no case reports have identified bre.. View More»
  DOI: 10.35248/2167-1044.20.9.355

  Abstract HTML PDF